Kategori: News

What’s New at Capitainer: Clinical Trials, Creatinine Validation, Laboratory Workflows & A New Addition to the Team

The year is off to a strong start. From new peer-reviewed evidence and public attention around blood-based Alzheimer’s biomarkers, to practical insights on microsampling workflows: here are some January highlights fro m Capitainer. 

What’s New at Capitainer: 20% off SEP10, Alzheimer’s Biomarkers & an exciting webinar from PCSIG

The year is off to a strong start. From new peer-reviewed evidence and public attention around blood-based Alzheimer’s biomarkers, to practical insights on microsampling workflows: here are some January highlights fro m Capitainer. 

What’s New at Capitainer: 2025 – A Year of Progress, Partnerships & Decentralized Care 

As the year comes to a close, we’d like to take a moment to reflect on what has been an important and eventful year for Capitainer.  From clinical research and healthcare implementations to new product launches, partnerships, and international growth – 2025…

What’s New at Capitainer: Updated Product & Research Highlights 

Welcome to this month’s update from Capitainer. It’s only been three weeks since our last newsletter…

What’s New at Capitainer – Product launch, automation and SKUP results

October flew by – We officially launched Capitainer®DIP70, expanding self-sampling beyond blood and plasma, while the SKUP…

What’s New at Capitainer – Lead, Thyroid & Alzheimer’s

From tackling lead testing challenges to enabling new thyroid testing services with Life Genomics, and exploring…

What’s new at Capitainer – from global projects to local impact

From EU-funded collaborations to new colleagues and upcoming webinars, there’s plenty happening at Capitainer right now.…

What’s new at Capitainer – and where to meet us

A lot has happened since our last update – including the launch of our new webpage.…

Capitainer Wins the Prestigious Medtech4Health Innovation Award 2025

We are proud to announce that Capitainer has been awarded the prestigious Medtech4Health Innovation Award 2025…

Capitainer Device Selected for Major Swedish Handball Concussion Study

Capitainer is delighted to announce that its blood collection devices have been selected for SWECON (The…

Alzheimer’s Diagnostics Redefined: Professor Zetterberg on Biomarkers, Plasma Sampling, and the Future of Dementia Research

In an interview with Technology Networks, Professor Henrik Zetterberg discussed recent advancements in dementia diagnostics, emphasizing…

Major kidney study involving Capitainer featured in Scandinavian healthcare magazines

Capitainer is proud to see its blood self-sampling technology featured in leading healthcare publications in Sweden,…

Proteomics study with Capitainer featured in two articles

Capitainer is proud to be featured in two recent articles; one article by GenomeWeb, entitled Swedish…

Overcome the challenges of dried blood spot sampling with quantitative DBS technology – new editorial article in SelectScience

In a new published editorial in SelectScience, based on an interview with the principal scientist of…

Capitainer and The Human Protein Atlas in focus in article in leading Swedish newspaper

In a recent article in Dagens Industri, Sweden’s leading business newspaper, Capitainer’s shareholder Professor Mathias Uhlén…

Dr. Gang Liu joins the team of microsampling product Specialists of Capitainer

We are happy to welcome Dr. Gang Liu to our team of microsampling product specialists. Liu…

Fabio Castillo Martinez Strengthens The R&D Team

We are proud and happy to welcome Fabio Castillo as a new member of our R&D team. Fabio…

Revolutionizing Blood Sampling: Capitainer’s qDBS Technology in the SelectScience Spotlight

Capitainer’s self-sampling platform allows people to collect blood samples from their fingertips, anytime and anywhere, and…

Application note from Waters on immunosuppressive drug analysis using Capitainer®B

In a new application note Waters describes a clinical research method using liquid-liquid extraction from Capitainer®B…

Improved 17-OHP analysis with Capitainer®

The qDBS technology of Capitainer® was recently shown to significantly improve monitoring for PKU positive patients…